NEWS: Chlorpheniramine Naloxone Oxazepam Prednisolone Plendil Insulin. Neomycin Amoxil Furazolidone Thiotepa Dilantin Plendil! Amitriptyline Trandolapril Risperdal Benadryl Naproxen Dulcolax Beclomethasone Morphine Quinidine Aldara Dolasetron Ethanol Acetylcholine Phenacetin! Fenoterol Avalide Diethylpropion Cytomel, Elocon Tolazamide Disopyramide Glimepiride Cycloserine Chlordiazepoxide: Naloxone Cephalothin. Benicar Dextroamphetamine Hexoprenaline Levitra Podofilox Midodrine: Cyproheptadine Isradipine Fenoprofen Cefamandole, Darvocet Granisetron Cefatrizine Estrone Pyridostigmine Butalbital Belladonna Phenylephrine Levlen Trovafloxacin Avodart Warfarin Ethinyl Gemfibrozil. Mephentermine Cefprozil Nylidrin Diphenoxylate Xanax Methantheline Adipex Ibuprofen? Carbachol Dyphylline Chlordiazepoxide Dantrolene? Vytorin Ceftriaxone Phencyclidine Indinavir? Paregoric Demerol Levothyroxine Ceftibuten Iodoquinol Cycrimine Buclizine Mefloquine, Danazol Colace Zoloft Primidone: Viagra Piroxicam Cardizem Cloxacillin Promazine Paromomycin Pilocarpine Butorphanol Pravastatin Toprol Epoprostenol Promazine Digitalis Nizoral Foradil Oxycontin Hydroflumethiazide Enoxaparin Dilaudid Piperidolate Singulair Tretinoin Thiothixene Propylthiouracil Bethanechol Erythrityl Fentanyl Prochlorperazine! Lopressor Dimethindene. Isopropamide Cholestyramine! Demeclocycline Piperacillin Amikacin Prometrium Zileuton Lozol Nitrofurantoin Moxalactam Trimethoprim Sinemet Corticotropin Carbenicillin: Esomeprazole Miconazole Doxepin Hydromorphone Hydromorphone Desyrel! Probucol Echothiophate Ethchlorvynol Hydroxychloroquine! Hydrochlorothiazide Prozac Trimetrexate Somatostatin Adapalene Doxorubicin? Disulfiram Streptomycin Pheniramine Lunesta Ergocalciferol Pargyline Bleomycin Maprotiline Pantothenic Terbinafine Penicillin Acarbose Cerivastatin Amaryl Guanabenz Climara: Mestranol Aminopterin Clotrimazole Chantix Trientine Amantadine Cocaine Heroin Aprotinin Carteolol Mifepristone Oxytetracycline. Naratriptan Xanax: Cosopt Metoprolol, Clomocycline Flagyl Phensuximide Cortisol Botox Acebutolol Ditropan Chlortetracycline Diovan Nialamide! Betamethasone Chlorothiazide Suboxone Ketoprofen Protonix Lotrel! Methamphetamine Dichlorphenamide Perindopril Isocarboxazid: Iodine Prednisone Augmentin Sildenafil! Tacrolimus Tolmetin! Ethinamate Dalteparin Pseudoephedrine Thiabendazole Acarbose Vytorin Norvasc Diethylstilbestrol Nafcillin Acyclovir. Protriptyline Yohimbine Daunorubicin Guaifenesin Sulfasalazine Celiprolol Amoxapine Bricanyl Gatifloxacin Oxybutynin Diethylstilbestrol Demecarium Medrol Concerta Methacycline Vincristine Butorphanol Mucomyst Digoxin Dioxyline Trileptal Methoxsalen Acebutolol Casanthranol: Pediacare Ergocalciferol:

Can Outperforming Funds Be Identified in Advance? New Research Says “Yes”

A recent article at 24/7 Wall St. points to what the author describes as the Dumbest Column of the Year

As the end of the column makes clear, however, Middleton is not content to just trash one of the best-performing mutual funds of all time: He wants to condemn the whole indexing movement. To wit:

…over longer periods, indexes do not compare favorably with above-average mutual funds, and they are shamed by really good ones. Here are examples:

Middleton then lists four indices–the S&P 500, the S&P Mid-Cap, the S&P Small-cap, and the MSCI EAFE International–followed by the “average” fund for each asset class and a couple of funds that have beaten the indices. In every case, not surprisingly, the “average fund” lagged the appropriate index in most of the time periods shown. Also not surprisingly, the top performers beat the indices.

So where’s the stupidity? As usual, in the omissions.

First, because Middleton has demonstrated after the fact that some funds beat their benchmarks, he wants his readers to believe that such funds would have been easy to identify ahead of time. Again, half a century of academic research suggests otherwise.

Actually, recent research indicates that it is possible to identify outperforming funds in advance - or at least to bring the odds of doing so to nearly 60%, and a weighted average portfolio of the “best” managers under this selection process returned 3% (300 basis points) more per year than the benchmark return.

The research in question, The Right Answer to the Wrong Question: Identifying Superior Active Portfolio Management by Harlow and Brown, was published in the Journal of Investment Management, Fourth Quarter 2006.

For more information, see all articles on: Investment Returns, Research, Security Selection

See also:
  • Do Market Timing Hedge Funds Time the Market?
  • Due Diligence for Hedge Fund Managers
  • Determinants of Funds of Hedge Funds Performance
  • Research and Development Expense
  • The Efficient Market Hypothesis and Index Funds
  • Technical Analysis Explained : The Successful Investor's Guide to Spotting Investment Trends and Turning Points

    The Intelligent Investor: The Classic Text on Value Investing

    Financial Statement Analysis: A Practitioner's Guide, 3rd Edition

    Managing Investment Portfolios: A Dynamic Process (CFA Institute Investment Series)

    One Response to “Can Outperforming Funds Be Identified in Advance? New Research Says “Yes””

    1. The Festival of Stocks - Stock Market Beat - Our beat: The stock market. Our job: Beat it. Says:

      [...] Project Stocks submitted Beat the Market With Only 15 Minutes of Work Each Year. The idea is to buy each year’s top performing fund and hold it for a year. Seems simplistic, but it actually has some support from recent academic research. [...]

    Leave a Reply

    You must be logged in to post a comment.

    ss_blog_claim=03ab3ad958d87eac8403bc8f2fe29a6d